Key Developments: DiaSorin SpA (DIAS.MI)

DIAS.MI on Milan Stock Exchange

17 Apr 2014
Price Change (% chg)

€0.01 (+0.03%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Latest Key Developments (Source: Significant Developments)

DiaSorin SpA announces 0.55 euros per share dividend for FY 2013; issues FY 2014 revenues and EBITDA guidance
Thursday, 6 Mar 2014 08:19am EST 

DiaSorin SpA:Says the Board approved the motion for the allocation of the net profit for fiscal year 2013, including the payment of a gross dividend of 29,919,041.35 euros, equal to 0.55 euros per share, with the exception of treasury shares.Ex-dividend on May 19, record date on May 21 and payment on May 22.Sees for fiscal year 2014 revenues growth between 3 pct and 5 pct at CER compared with 2013.Sees fiscal year 2014 EBITDA growth equal to ca. 3 pct at CER compared with 2013.  Full Article

DiaSorin SpA launches new N-TACT PTH Gen II on LIAISON platform
Tuesday, 18 Feb 2014 07:01am EST 

DiaSorin SpA:Says it launched a new product in its portfolio, the LIAISON N-TACT PTH Gen II assay, for the quantitative determination of intact human parathyroid hormone (PTH) in human serum and plasma.Says the LIAISON N-TACT PTH Gen II assay is a redevelopment of the existing N-TACT PTH assays and employs specific polyclonal antibodies to assist in diagnosis of disorders of calcium metabolism.Says this assay is an addition to the current DiaSorin LIAISON Bone and Mineral menu made of both specialty and main stream tests such as the 25-OH Vitamin D TOTAL Assay, 1-84 PTH, BAP OSTASE and Osteocalcin.  Full Article

DiaSorin SpA launches the Rotavirus test on LIAISON stool sample
Tuesday, 11 Feb 2014 05:48am EST 

DiaSorin SpA:Says it launched the LIAISON Rotavirus test for the qualitative detection of Rotavirus in stool specimens, available in the market outside the US and UK only.Says the new LIAISON Rotavirus is the fifth test launched on the LIAISON Stool menu, in addition to the other tests already on the market (C. difficile Toxin AB, C. Difficile GDH, H. pylori, EHEC) since 2013.Says DiaSorin's LIAISON solution aims at improving the way Rotavirus test is performed to date.  Full Article

DiaSorin SpA extends its relationship with Laboratory Corporation of America Holdings
Tuesday, 28 Jan 2014 04:41am EST 

DiaSorin SpA:Says it has signed a 3 year extension of its master agreement, through the end of 2018, with Laboratory Corporation of America Holdings (LabCorp).Says the purpose of the agreement extension is to expand DiaSorin’s LIAISON XL menu offering to LabCorp, while maintaining the existing Vitamin D business.Says DiaSorin will add 15 new assays to the current menu for LabCorp, which will expand its offering of DiaSorin tests in new clinical areas.  Full Article

DiaSorin SpA obtains approval of hepatitis, retrovirus and syphilis tests on Liaison XL platform in China
Friday, 24 Jan 2014 02:41am EST 

DiaSorin SpA:Announces the obtainment of all the marketing approvals for Hepatitis, Retroviral and Syphilis assays on its LIAISON XL platform for the Chinese market.Says new tests include the complete panel of hepatitis B, hepatitis C, HIV and Treponema Assays.  Full Article

DiaSorin SpA launches its fifth molecular diagnostic test for the detection and quantification of cytomegalovirus
Thursday, 9 Jan 2014 12:24pm EST 

DiaSorin SpA:Announces the launch of a new molecular diagnostic test for the detection and quantification of Cytomegalovirus (CMV) on human fluid samples, available on the market outside of the United States and Canada.Says new IAM CMV is the fifth test used on the LIAISON IAM after the first four assays already launched in 2012 and 2013 (IAM BKV, IAM VZV, IAM PARVO, IAM TOXO).  Full Article

YOOX SpA enters FTSE MIB of Borsa Italiana on Dec. 23 and DiaSorin SpA and Parmalat exit-Reuters
Tuesday, 10 Dec 2013 07:00pm EST 

YOOX SpA:As mentioned in a press release of Borsa Italiana and FTSE, starting from Dec. 23 the FTSE MIB index of Borsa Italiana, the Italian Stock Exchange, will reduce to 40 company, from the 41 present to date-Reuters.As of Dec. 23 YOOX will enter FTSE MIB and DiaSorin SpA and Parmalat will be exiting it.The imbalance between entering and exiting companies from the FTSE MIB is due to the necessity to bring the number of companies listed on FTSE MIB to 40 after the temporary increase to 41 following Autogrill's spin-off in October.  Full Article

DiaSorin SpA Signs 5-Year Cooperation Agreement With Roche Holding AG
Tuesday, 29 Oct 2013 04:00am EDT 

DiaSorin SpA announced that it has signed a 5-year agreement with Roche Holding AG, to allow the connectivity of the LIAISON XL System to the cobas 8100 automated workflow series in the High Volume Laboratories requesting to fully automate their diagnostic processes. The agreement also allows Roche to exclusively represent part of the DiaSorin's specialty assays in this market segment, in association with the Cobas 8100 platform.  Full Article

DiaSorin SpA Launches The EHEC Toxins Test On Its LIASION Platform
Friday, 25 Oct 2013 06:16am EDT 

DiaSorin SpA announced the launch of the EHEC Toxins test on its LIAISON platform for the market outside the United States, Canada and United Kingdom only. The LIAISON EHEC Toxins assay is intended for the qualitative detection of Shiga toxins 1 and 2 in stool samples and is an aid in the diagnosis of Enterohaemorrhagic E. coli (EHEC) with CLIA technology.  Full Article

DiaSorin SpA Launches On LIAISON XL Platform the New Test for Detection of IgC Antibodies to Trypanosoma Cruzi Which Causes Chagas, for Market Outside US and Canada
Thursday, 10 Oct 2013 04:55am EDT 

DiaSorin SpA announced the introduction of the new LIAISON XL Chagas test for the qualitative detection of the antibodies to Trypanosoma cruzi (T.cruzi) in human serum and plasma for the market outside the US and Canada only. Chagas disease, or American trypanosomiasis, is an infectious disease transmitted by the Triatomine bug when it deposits its feces on the host's skin surface and subsequently bites it. However the disease can also be transmitted through blood donations, organ transplants or mother to child. The Chagas disease is endemic in Central and Latin American countries, growing also in non-endemic countries through migration of people and, becoming nowadays, an emerging health problem worldwide. This new test on the LIAISON XL platform is an addition to the extensive infectious disease menu which now reaches 45 tests and represents a further increasing of the menu for the blood banks’ market.  Full Article

Diasorin 2013 net profit falls 11 pct on exchange rate

MILAN, March 6 - Italian medical diagnostics group Diasorin said on Thursday its net profit last year fell 11.4 percent to 81.8 million euros as exchange rate fluctuations and costs to support its molecular business took their toll on margins.

Search Stocks